Dermatology · Cincinnati, OH
NPI
1407947872
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
4460 Red Bank Rd Ste 130
Cincinnati, OH, 45227
Phone (513) 579-9191
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
3,175 services
Medicare patients, 2024
739
Average age 75
Drug cost, 2024
$243K
1,379 prescriptions
Company payments, 2025
$17.79
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca W Short was code 17003 (destruction skin lesion), 1,252 times for 188 patients. In total Rebecca W Short billed 3,175 services in 24 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,252 | 188 | $4.55 | $5,703 |
| 99213 Office E&M - Established | Office | 628 | 555 | $55.03 | $35K |
| 17000 Destruction Skin Lesion | Office | 231 | 218 | $31.17 | $7,201 |
| 11102 Skin Biopsy | Office | 229 | 213 | $60.63 | $14K |
| 17110 Destruction Skin Lesion | Office | 214 | 186 | $67.10 | $14K |
| 17004 Destruction Skin Lesion | Office | 185 | 180 | $83.34 | $15K |
| 11103 Skin Biopsy | Office | 176 | 91 | $37.24 | $6,555 |
| 99214 Office E&M - Established | Office | 140 | 130 | $80.78 | $11K |
| 99203 Office E&M - New | Office | 56 | 56 | $59.65 | $3,340 |
| 99204 Office E&M - New | Office | 24 | 24 | $105.42 | $2,530 |
By year: 2022 $164K for 6,130 services; 2023 $164K for 4,293 services; 2024 $117K for 3,175 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca W Short prescribed most often to Medicare patients was Triamcinolone Acetonide, with 155 prescriptions and refills. In total Rebecca W Short wrote 1,379 Medicare prescriptions that cost $243K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 155 | 175 | 93 | $1,005 |
| Ketoconazole Generic | 150 | 176 | 71 | $1,696 |
| Fluorouracil Generic | 106 | 115 | 95 | $7,388 |
| Betamethasone Valerate Generic | 85 | 92 | 57 | $1,718 |
| Doxycycline Monohydrate Generic | 70 | 75 | 49 | $1,356 |
| Mometasone Furoate Generic | 69 | 77 | 47 | $1,138 |
| Mupirocin Generic | 66 | 66 | 57 | $414 |
| Clobetasol Propionate Generic | 59 | 59 | 39 | $1,739 |
| Metronidazole Generic | 57 | 60 | 32 | $2,302 |
| Fluocinonide Generic | 55 | 56 | 31 | $1,863 |
| Nystatin Generic | 44 | 45 | 26 | $559 |
| Valacyclovir Valacyclovir Hcl | 41 | 58 | Under 11 | $828 |
| Otezla Apremilast | 31 | 31 | Under 11 | $151K |
| Erythromycin Erythromycin Base In Ethanol | 31 | 32 | 19 | $1,326 |
| Ciclopirox Generic | 27 | 29 | 15 | $491 |
Brand drugs: 107 claims; generic drugs: 1,272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca W Short $17.79 ($17.79 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $17.79.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $17.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.